GALEAZZI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 602
EU - Europa 517
AS - Asia 141
AF - Africa 5
Totale 1.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 599
RU - Federazione Russa 285
IT - Italia 65
IE - Irlanda 64
SE - Svezia 55
HK - Hong Kong 38
SG - Singapore 37
JO - Giordania 29
CN - Cina 23
CH - Svizzera 15
PL - Polonia 14
DE - Germania 11
IN - India 11
GB - Regno Unito 5
CI - Costa d'Avorio 4
CA - Canada 3
FI - Finlandia 3
VN - Vietnam 2
SC - Seychelles 1
TR - Turchia 1
Totale 1.265
Salva come PNG Salva come JPEG
Città #
Santa Clara 121
Chandler 66
Dublin 64
Fairfield 59
Woodbridge 35
Altamura 29
Ashburn 29
Lawrence 29
Singapore 28
Hong Kong 24
Seattle 23
Wilmington 23
Cambridge 18
Houston 18
Princeton 16
Buffalo 15
Bern 14
Warsaw 14
Boston 13
Florence 10
Mumbai 10
Shanghai 10
Ann Arbor 8
Boardman 6
Falls Church 6
Moscow 6
Beijing 5
Kent 5
Medford 5
Rome 5
Abidjan 4
Andover 3
Castelliri 3
Redwood City 3
Taizhou 3
Toronto 3
Capannori 2
Dong Ket 2
Los Angeles 2
Milan 2
New York 2
Norwalk 2
Padova 2
San Diego 2
Wernigerode 2
West Jordan 2
Yubileyny 2
Esslingen am Neckar 1
Frankfurt Am Main 1
Helsinki 1
Hillsboro 1
Irkutsk 1
Kilburn 1
London 1
Monmouth Junction 1
Pieve 1
Pune 1
Trumbull 1
Wandsworth 1
Totale 767
Salva come PNG Salva come JPEG
Nome #
Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: A proof of concept study 127
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 96
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 91
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 90
Long-term Retention Rates of Adalimumab and Infliximab in Non-Infectious Intermediate, Posterior, and Panuveitis 82
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 81
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 80
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 79
FRI0586 Interleukin (IL)-1 inhibition with anakinra and canakinumab in behÇet's disease related uveitis: a multicenter retrospective observational study 76
THU0540 Efficacy and safety of adalimumab in behÇet's disease related uveitis: a multicenter retrospective observational study 74
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 67
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 66
BONE STATUS OF CHILDREN BORN FROM MOTHERS WITH AUTOIMMUNE DISEASES TREATED DURING PREGNANCY WITH LOW MOLECULAR WEIGHT HEPARIN AND/OR PREDNISONE 64
Prompt Clinical Response to Secukinumab in Patients With Axial Spondyloarthritis: Real Life Observational Data From Three Italian Referral Centers 61
Different Drug Survival of First Line Tumour Necrosis Factor Inhibitors in Radiographic and Non-Radiographic Axial Spondyloarthritis: A Multicentre Retrospective Survey 59
C13 COMPARISON OF MINIMALLY INVASIVE VERSUS CONVENTIONAL THORACIC AORTIC OPERATIONS: EARLY AND MID–TERM RESULTS IN A SERIES OF 624 PATIENTS 50
Comparison of minimally invasive versus conventional thoracic aortic operations: Early and midterm results in a series of 624 patients 50
Totale 1.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 8 9 9 10 8 5 2 22
2020/2021141 7 16 15 10 4 6 29 12 12 14 3 13
2021/202292 4 3 3 5 2 3 0 7 3 5 18 39
2022/2023350 30 84 13 5 27 55 39 20 45 0 15 17
2023/2024118 4 16 18 8 9 7 9 29 1 5 6 6
2024/2025487 35 97 51 176 128 0 0 0 0 0 0 0
Totale 1.293